Anamorelin
Cat.No:IA3330 Solarbio
CAS:249921-19-5
Molecular Formula:C31H42N6O3
Molecular Weight:546.7
Storage:Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Off-white to yellow Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
GPCR & G Protein >
AnamorelinCAS:249921-19-5
Molecular Formula:C31H42N6O3
Molecular Weight:546.7
Storage:Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Off-white to yellow Solid
Qty:
Size:
CAS | 249921-19-5 |
Name | Anamorelin |
Molecular Formula | C31H42N6O3 |
Molecular Weight | 546.7 |
Solubility | Soluble in DMSO |
Purity | ≥98% |
Appearance | Off-white to yellow Solid |
Storage | Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
SMILES | [H][C@](CC1=CNC2=CC=CC=C21)(NC(C(C)(C)N)=O)C(N3CCC[C@@](C(N(C)N(C)C)=O)(CC4=CC=CC=C4)C3)=O |
Target Point | ghrelin receptor |
Passage | GPCR & G Protein |
Background | Anamorelin is a novel ghrelin receptor agonist. |
Biological Activity | Anamorelin (RC-1291) is a potent ghrelin receptor agonist with EC50 value of 0.74 nM in the FLIPR assay.[1] |
IC50 | Ki: 0.7nM(ghrelin receptor)[1] |
Data Literature Source | [1]. Pietra C,et al. Anamorelin HCl (ONO-7643),a novel ghrelin receptor agonist,for the treatment of cancer anorexia-cachexiasyndrome: preclinical profile. J Cachexia Sarcopenia Muscle. 2014 Dec;5(4):329-37. |
Unit | Bottle |
Specification | 5mg 10mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.